10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0000914475-20-000036`
Period End Date	20200930
Filing Date	20201109
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	nbix-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 80 Cash Flow Statement 58 Stockholders Equity 32

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Amortized cost, current	`DebtSecuritiesAvailableForSaleAmortizedCostCurrent`	$557.30M	USD	Point-in-time
Amortized cost, current	`DebtSecuritiesAvailableForSaleAmortizedCostCurrent`	$517.30M	USD	Point-in-time
Amortized cost, noncurrent	`DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent`	$180.30M	USD	Point-in-time
Amortized cost, noncurrent	`DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent`	$299.30M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$112.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$425.30M	USD	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $517.3 million at September 30, 2020 and $557.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$519.40M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $517.3 million at September 30, 2020 and $557.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$558.20M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$156.90M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$126.60M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$20.60M	USD	Point-in-time
Inventories	`InventoryNet`	$17.30M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.60M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$34.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.16B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$831.00M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $180.3 million at September 30, 2020 and $299.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$299.70M	USD	Point-in-time
Debt securities available-for-sale, at fair value (amortized cost $180.3 million at September 30, 2020 and $299.3 million at December 31, 2019)	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$181.40M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	92.30M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	93.40M	shares	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$74.30M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	92.30M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	93.40M	shares	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.00M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$55.90M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$43.70M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$43.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$41.90M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.20M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.20M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$3.40M	USD	Point-in-time
Total assets	`Assets`	$1.50B	USD	Point-in-time
Total assets	`Assets`	$1.31B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$141.30M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$170.50M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtCurrent`	$408.80M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtCurrent`	$425.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$15.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$15.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$611.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$565.30M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$86.70M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$83.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.10M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$669.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$698.30M	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding at September 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; issued and outstanding shares were 93.4 at September 30, 2020 and 92.3 at December 31, 2019	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; issued and outstanding shares were 93.4 at September 30, 2020 and 92.3 at December 31, 2019	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.77B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.87B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$3.20M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.07B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$831.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$483.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$574.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$804.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$636.90M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.50B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.31B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$258.50M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$798.00M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$222.10M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$544.00M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.20M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$7.20M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$4.90M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.70M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$45.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$69.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$208.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$144.70M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$118.50M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$164.50M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$118.10M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	-	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$252.80M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$84.50M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$326.80M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$112.50M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$132.00M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$520.50M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$302.80M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$706.80M	USD	3 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-44.30M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$90.10M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$23.50M	USD	3 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$91.20M	USD	3 Qtrs
Interest expense	`InterestExpense`	$23.80M	USD	3 Qtrs
Interest expense	`InterestExpense`	$25.00M	USD	3 Qtrs
Interest expense	`InterestExpense`	$8.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.50M	USD	1 Quarter
Unrealized loss on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-12.20M	USD	3 Qtrs
Unrealized loss on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.80M	USD	3 Qtrs
Unrealized loss on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-7.00M	USD	1 Quarter
Unrealized loss on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-28.50M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$11.00M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.80M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$14.00M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$2.70M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-15.60M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-12.80M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-31.70M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-26.20M	USD	3 Qtrs
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$65.00M	USD	3 Qtrs
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-57.10M	USD	1 Quarter
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.90M	USD	3 Qtrs
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$58.40M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.90M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.60M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$500.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.60M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-57.60M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$53.80M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$3.00M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$59.40M	USD	3 Qtrs
Unrealized (loss) gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.40M	USD	1 Quarter
Unrealized (loss) gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$3.60M	USD	3 Qtrs
Unrealized (loss) gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Unrealized (loss) gain on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.80M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$54.80M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$61.20M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$6.60M	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-59.00M	USD	1 Quarter
Net (loss) income per share, basic (in USD per share)	`EarningsPerShareBasic`	$-0.62	USD	1 Quarter
Net (loss) income per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.64	USD	3 Qtrs
Net (loss) income per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.59	USD	1 Quarter
Net (loss) income per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Net (loss) income per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.62	USD	1 Quarter
Net (loss) income per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.56	USD	1 Quarter
Net (loss) income per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.61	USD	3 Qtrs
Net (loss) income per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.30M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	91.40M	shares	3 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.00M	shares	3 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	91.90M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.10M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.00M	shares	3 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.20M	shares	3 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.30M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$-57.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$53.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$59.40M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$79.00M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$54.00M	USD	3 Qtrs
Depreciation	`Depreciation`	$6.40M	USD	3 Qtrs
Depreciation	`Depreciation`	$5.40M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$14.10M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$15.20M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.00M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.00M	USD	3 Qtrs
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-12.20M	USD	3 Qtrs
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-5.80M	USD	3 Qtrs
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-7.00M	USD	1 Quarter
Change in fair value of equity security investments	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-28.50M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$1.70M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-700.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$30.30M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$57.90M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.40M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-100.00K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$28.10M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.30M	USD	3 Qtrs
Other assets and liabilities, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$29.70M	USD	3 Qtrs
Other assets and liabilities, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-12.40M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$49.50M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$139.60M	USD	3 Qtrs
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$467.10M	USD	3 Qtrs
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$399.20M	USD	3 Qtrs
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$557.40M	USD	3 Qtrs
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$488.80M	USD	3 Qtrs
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	-	USD	3 Qtrs
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	$54.70M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.40M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.90M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$151.80M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.90M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$21.60M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$20.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$21.60M	USD	3 Qtrs
Change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$313.00M	USD	3 Qtrs
Change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.60M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$428.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$171.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$428.50M	USD	Point-in-time
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.10M	USD	3 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$100.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.80M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.80M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$400.00K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$500.00K	USD	3 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$831.20M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$483.70M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$574.50M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$804.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$636.90M	USD	Point-in-time
Net income	`NetIncomeLoss`	$-57.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$53.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.00M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$59.40M	USD	3 Qtrs
Unrealized gain (loss) on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.80M	USD	3 Qtrs
Unrealized gain (loss) on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.40M	USD	1 Quarter
Unrealized gain (loss) on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.00M	USD	1 Quarter
Unrealized gain (loss) on debt securities available-for-sale, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.60M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$54.00M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$26.70M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.30M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$79.00M	USD	3 Qtrs
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$21.60M	USD	3 Qtrs
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$20.00M	USD	3 Qtrs
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.10M	USD	1 Quarter
Issuance of common stock for stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.50M	USD	1 Quarter
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.60M	USD	3 Qtrs
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.10M	USD	3 Qtrs
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.90M	USD	1 Quarter
Issuance of common stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.60M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$831.20M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$483.70M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$574.50M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$804.30M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$636.90M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.